ENTPD1 and ovarian carcinoma: CD39 expression is increased in various human tumors, including melanoma, colon cancer, ovarian cancer, pancreatic cancer, kidney cancer, lung cancer, thyroid cancer, testicular cancer, sarcoma, lymphoma, and chronic lymphocytic leukemia [42–46].